New study tests Scope-Based cancer removal as surgery alternative

NCT ID NCT03039309

Recruiting now Disease control Sponsor: Portsmouth Hospitals NHS Trust Source: ClinicalTrials.gov ↗

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study looks at how well a procedure called endoscopic submucosal dissection (ESD) works for removing early-stage cancers in the digestive tract. ESD uses a special knife on a thin tube to cut out abnormal tissue in one piece, avoiding open surgery. Researchers are tracking 500 adults in the UK to see how often the cancer is completely removed and how safe the procedure is over two years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Endoscopic submucosal dissection (a procedure using an endoscopic knife to remove lesions in the gastrointestinal tract)
What this could lead to: If successful, this could confirm endoscopic submucosal dissection as a reliable, less invasive alternative to surgery for early gastrointestinal cancers.
What could go wrong: This is an observational study, not a randomized trial, so results may not prove superiority over other treatments. Complications such as bleeding or perforation are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOSCOPIC SUBMUCOSAL DISSECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOSCOPIC SUBMUCOSAL DISSECTION

Contacts and locations

Locations

Portsmputh Hospitals NHS Trust
RECRUITING

Portsmouth, PO6 3LY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.